Chinnor, England, GB
New Startup (0-1M TTM Revenue)
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Our state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. We are authorised under EMA for the production of gene therapy products for clinical and commercial supply.
We offer services across a wide range of viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. From our cutting-edge fully-licensed GMP manufacturing facility in Finland, we have built an extensive pipeline of gene therapy products and technologies for our clients.
|FinVector Oakley Road , , OX39 4TW United Kingdom|
|FinVector 1 Microkatu Kuopio, , 70150 Finland|
|FinVector Oakley Road Chinnor, England, OX39 United Kingdom|
To request access, simply fill out the form below and we will contact you.